British Journal of Haematology

Papers to be published in forthcoming issues
pp. x-x(1)

Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia
pp. 447-447(1)

Loss of skin pigment caused by imatinib therapy
pp. 448-448(1)

Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
pp. 449-464(16)
Authors: Machado, Roberto F.; Gladwin, Mark T.

Predicting clinical severity in sickle cell anaemia
pp. 465-481(17)
Author: Steinberg, M. H.

Bone involvement in sickle cell disease
pp. 482-490(9)
Authors: Almeida, Antonio; Roberts, Irene

Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1
pp. 491-498(8)
Authors: Rothman, Rachel; Trakhtenbrot, Luba; Bielorai, Bella; Izraeli, Shai; Ishoev, Galina; Amariglio, Ninette; Rechavi, Gideon; Toren, Amos

Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia
pp. 499-510(12)
Authors: Mauerer, Katja; Zahrieh, David; Gorgun, Gullu; Li, Aihong; Zhou, Jianbiao; Ansén, Sascha; Rassenti, Laura Z.; Gribben, John G.

Phenotype and frequency of Epstein–Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma
pp. 511-519(9)
Authors: Khan, Gulfaraz; Lake, Annette; Shield, Lesley; Freeland, June; Andrew, Linda; Alexander, Freda E.; Jackson, Robert; Taylor, Penelope R. A.; McCruden, Elizabeth A. B.; Jarrett, Ruth F.

Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study
pp. 520-530(11)
Authors: Harrison, Christine J.; Moorman, Anthony V.; Barber, Kerry E.; Broadfield, Zoë J.; Cheung, Kan L.; Harris, Rachel L.; Reza Jalali, G.; Robinson, Hazel M.; Strefford, Jonathan C.; Stewart, Adam; Wright, Sarah; Griffiths, Mike; Ross, Fiona M.; Harewood, Louise; Martineau, Mary

Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas
pp. 531-533(3)
Authors: Gouw, Launce G.; Scott Reading, N.; Jenson, Stephen D.; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome
pp. 534-538(5)
Authors: Koneti Rao, V.; Dugan, Faith; Dale, Janet K.; Davis, Joie; Tretler, Jean; Hurley, John K.; Fleisher, Thomas; Puck, Jennifer; Straus, Stephen E.

The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system
pp. 539-541(3)
Authors: Chang, Hong; Bartlett, Eric S; Patterson, Bruce; Chen, Chris I; Yi, Qi Long

Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia
pp. 542-549(8)
Authors: Yoshimi, Ayami; Niemeyer, Charlotte M.; Bohmer, Viktoria; Duffner, Ulrich; Strahm, Brigitte; Kreyenberg, Hermann; Dilloo, Dagmar; Zintl, Felix; Claviez, Alexander; Wössmann, Willi; Kremens, Bernhard; Holter, Wolfgang; Niethammer, Dietrich; Beck, James F.; Kontny, Udo; Nöllke, Peter; Klingebiel, Thomas; Bader, Peter

Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease
pp. 550-552(3)
Authors: Woodard, Paul; Helton, Kathleen J.; Khan, Raja B.; Hale, Gregory A.; Phipps, Sean; Wang, Winfred; Handgretinger, Rupert; Cunningham, John M.

Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis
pp. 553-560(8)
Authors: Chait, Yasmine; Condat, Bertrand; Cazals-Hatem, Dominique; Rufat, Pierre; Atmani, Sai; Chaoui, Driss; Guilmin, Françoise; Kiladjian, Jean Jacques; Plessier, Aurélie; Denninger, Marie Hélène; Casadevall, Nicole; Valla, Dominique; Brière, Jean B.

Protein Z-dependent protease inhibitor W303X mutation in venous thrombosis
pp. 561-562(2)

Protein Z-dependent protease inhibitor W303X mutation in venous thrombosis: response to Gonzalez-Conejero et al
pp. 562-562(1)

Bone marrow biopsy in thrombocytopenic or anticoagulated patients
pp. 562-563(2)

The role of natural killer T (NKT) cells in immune thrombocytopenia: is strong in vitro NKT cell activity related to the development of remission?
pp. 564-565(2)

UK NEQAS for Blood Coagulation Annual Scientific Meeting and Special Symposium in Honour of Professor Eric Preston Sheffield Hallam University, Sheffield, UK 8–9 June 2005
pp. 566-566(1)